Close Menu

NEW YORK (GenomeWeb) – Waters disclosed in a filing with the US Securities and Exchange Commission on Friday that it has sold $250 million in senior notes to institutional accredited investors.

The mass spectrometry and chromatography equipment manufacturer didn't name the purchasers but said that it sold three series of senior notes in the private placement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.